Evaluation of an ICU-specific Questionnaire for Patient-reported Outcome Measures
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02767180 |
|
Recruitment Status :
Completed
First Posted : May 10, 2016
Last Update Posted : October 22, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Intensive Care Unit Syndrome |
| Study Type : | Observational |
| Estimated Enrollment : | 800 participants |
| Observational Model: | Cohort |
| Time Perspective: | Other |
| Official Title: | Evaluation of an Intensive Care Specific Questionnaire for Patient-reported Outcome |
| Actual Study Start Date : | April 2016 |
| Actual Primary Completion Date : | April 1, 2020 |
| Actual Study Completion Date : | September 1, 2020 |
| Group/Cohort |
|---|
|
Critical care survivors
Former ICU-patients recruited six months to three years after discharge from the ICU
|
|
Matched controls
Control patients who have not been critically ill, matched for age and sex.
|
- Patient reported outcome measured with an ICU-specific questionnaire [ Time Frame: Six months to 3 years after intensive care ]An ICU-specific questionnaire will be used which has been developed from interviews of former ICU-patients
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Patients treated in an intensive care unit at Sahlgrenska University for more than 72 hours and survived are included between 6 months and tre years after discharge from ICU.
- Control persons from the Swedish Population Registry matched for sex and gender are also included.
Exclusion Criteria:
- Patient with acute neurological/neurosurgical conditions and/or anoxic/hypoxic brain damage
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02767180
| Sweden | |
| Sahlgrenska University Hospital | |
| Gothenburg, Sweden, S-413 45 | |
| Principal Investigator: | Stefan Lundin, MD PhD | Dept of Anesthesia and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Stefan Lundin, Adjunct Professor, Sahlgrenska University Hospital, Sweden |
| ClinicalTrials.gov Identifier: | NCT02767180 |
| Other Study ID Numbers: |
LUA-74200 |
| First Posted: | May 10, 2016 Key Record Dates |
| Last Update Posted: | October 22, 2020 |
| Last Verified: | October 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |

